- Home
- AMLX vs MUX Comparison
AMLX vs MUX Comparison
Compare AMLX & MUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMLX
- MUX
- Stock Information
- Founded
- AMLX 2014
- MUX 1979
- Country
- AMLX United States
- MUX Canada
- Employees
- AMLX N/A
- MUX N/A
- Industry
- AMLX Biotechnology: Pharmaceutical Preparations
- MUX Precious Metals
- Sector
- AMLX Health Care
- MUX Basic Materials
- Exchange
- AMLX Nasdaq
- MUX Nasdaq
- Market Cap
- AMLX 481.9M
- MUX 443.5M
- IPO Year
- AMLX 2022
- MUX N/A
- Fundamental
- Price
- AMLX $4.05
- MUX $7.98
- Analyst Decision
- AMLX Buy
- MUX Strong Buy
- Analyst Count
- AMLX 7
- MUX 2
- Target Price
- AMLX $7.60
- MUX $15.63
- AVG Volume (30 Days)
- AMLX 786.1K
- MUX 524.3K
- Earning Date
- AMLX 11-07-2024
- MUX 11-05-2024
- Dividend Yield
- AMLX N/A
- MUX N/A
- EPS Growth
- AMLX N/A
- MUX N/A
- EPS
- AMLX N/A
- MUX 2.07
- Revenue
- AMLX $196,485,000.00
- MUX $199,634,000.00
- Revenue This Year
- AMLX N/A
- MUX $22.76
- Revenue Next Year
- AMLX N/A
- MUX $18.67
- P/E Ratio
- AMLX N/A
- MUX $3.86
- Revenue Growth
- AMLX N/A
- MUX 47.02
- 52 Week Low
- AMLX $1.58
- MUX $5.92
- 52 Week High
- AMLX $19.95
- MUX $12.50
- Technical
- Relative Strength Index (RSI)
- AMLX 36.50
- MUX 40.50
- Support Level
- AMLX $3.78
- MUX $7.78
- Resistance Level
- AMLX $4.40
- MUX $8.45
- Average True Range (ATR)
- AMLX 0.30
- MUX 0.40
- MACD
- AMLX -0.12
- MUX -0.05
- Stochastic Oscillator
- AMLX 15.52
- MUX 13.33
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder.
About MUX McEwen Mining Inc.
McEwen Mining Inc is a mining and minerals production and exploration company focused on precious and base minerals in Argentina, Mexico, and the United States. The company's overall revenue is principally derived from the production of gold and silver. The company owns and operates the wholly-owned El Gallo 1 mine in Mexico, and has a minority shareholding in the company that operates the San Jose mine in Argentina. More than half the company's gold output is produced by the El Gallo 1 mine. The remaining gold production, and the majority of silver production, is produced by the San Jose mine. Geographically, the majority is from Canada.